Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

SARS-CoV-2 D614G spike mutation increases entry efficiency with enhanced ACE2-binding affinity
Seiya Ozono, Yanzhao Zhang, Hirotaka Ode, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 491

Showing 1-25 of 491 citing articles:

Mechanisms of SARS-CoV-2 entry into cells
Cody B. Jackson, Michael Farzan, Bing Chen, et al.
Nature Reviews Molecular Cell Biology (2021) Vol. 23, Iss. 1, pp. 3-20
Open Access | Times Cited: 2439
SARS-CoV-2 Omicron variant replication in human bronchus and lung ex vivo
Kenrie P. Y. Hui, John Chi Wang Ho, Man Chun Cheung, et al.
Nature (2022) Vol. 603, Iss. 7902, pp. 715-720
Open Access | Times Cited: 746
The evolution of SARS-CoV-2
Peter V. Markov, Mahan Ghafari, Martin Beer, et al.
Nature Reviews Microbiology (2023) Vol. 21, Iss. 6, pp. 361-379
Open Access | Times Cited: 731
Enhanced fusogenicity and pathogenicity of SARS-CoV-2 Delta P681R mutation
Akatsuki Saito, Takashi Irie, Rigel Suzuki, et al.
Nature (2021) Vol. 602, Iss. 7896, pp. 300-306
Open Access | Times Cited: 549
SARS-CoV-2 spike L452R variant evades cellular immunity and increases infectivity
Chihiro Motozono, Mako Toyoda, Jiří Zahradník, et al.
Cell Host & Microbe (2021) Vol. 29, Iss. 7, pp. 1124-1136.e11
Open Access | Times Cited: 519
Evolution of enhanced innate immune evasion by SARS-CoV-2
Lucy Thorne, Mehdi Bouhaddou, Ann‐Kathrin Reuschl, et al.
Nature (2021) Vol. 602, Iss. 7897, pp. 487-495
Open Access | Times Cited: 333
Virological characteristics of the SARS-CoV-2 Omicron BA.2 spike
Daichi Yamasoba, Izumi Kimura, Hesham Nasser, et al.
Cell (2022) Vol. 185, Iss. 12, pp. 2103-2115.e19
Open Access | Times Cited: 312
mRNA vaccines for COVID-19: what, why and how
Jung Woo Park, Philip N.P. Lagniton, Yu Liu, et al.
International Journal of Biological Sciences (2021) Vol. 17, Iss. 6, pp. 1446-1460
Open Access | Times Cited: 268
Virological characteristics of the SARS-CoV-2 XBB variant derived from recombination of two Omicron subvariants
Tomokazu Tamura, Jumpei Ito, Keiya Uriu, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 256
Virological characteristics of the SARS-CoV-2 Omicron BA.2 subvariants, including BA.4 and BA.5
Izumi Kimura, Daichi Yamasoba, Tomokazu Tamura, et al.
Cell (2022) Vol. 185, Iss. 21, pp. 3992-4007.e16
Open Access | Times Cited: 238
Infection- and vaccine-induced antibody binding and neutralization of the B.1.351 SARS-CoV-2 variant
Venkata Viswanadh Edara, Carson Norwood, Katharine Floyd, et al.
Cell Host & Microbe (2021) Vol. 29, Iss. 4, pp. 516-521.e3
Open Access | Times Cited: 235
A Comprehensive Review of COVID-19 Virology, Vaccines, Variants, and Therapeutics
Lauren Forchette, William Sebastian, Tuoen Liu
Current Medical Science (2021) Vol. 41, Iss. 6, pp. 1037-1051
Open Access | Times Cited: 225
SARS-COV-2 Variants: Differences and Potential of Immune Evasion
Sandro Massao Hirabara, Tamires Duarte Afonso Serdan, Renata Gorjão, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 11
Open Access | Times Cited: 207
The SARS-CoV-2 Lambda variant exhibits enhanced infectivity and immune resistance
Izumi Kimura, Yusuke Kosugi, Jiaqi Wu, et al.
Cell Reports (2021) Vol. 38, Iss. 2, pp. 110218-110218
Open Access | Times Cited: 180
Transmission of SARS-CoV-2 delta variant (AY.127) from pet hamsters to humans, leading to onward human-to-human transmission: a case study
Hui‐Ling Yen, Thomas H. C. Sit, Christopher J. Brackman, et al.
The Lancet (2022) Vol. 399, Iss. 10329, pp. 1070-1078
Open Access | Times Cited: 172
Effects of SARS-CoV-2 variants on vaccine efficacy and response strategies
Lianlian Bian, Fan Gao, Jialu Zhang, et al.
Expert Review of Vaccines (2021) Vol. 20, Iss. 4, pp. 365-373
Open Access | Times Cited: 169
SARS-CoV-2 one year on: evidence for ongoing viral adaptation
Thomas P. Peacock, Rebekah Penrice-Randal, Julian A. Hiscox, et al.
Journal of General Virology (2021) Vol. 102, Iss. 4
Open Access | Times Cited: 167
Preliminary report on severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) Spike mutation T478K
Simone Di Giacomo, Daniele Mercatelli, A. N. Rakhimov, et al.
Journal of Medical Virology (2021) Vol. 93, Iss. 9, pp. 5638-5643
Open Access | Times Cited: 161
Molecular insights into receptor binding of recent emerging SARS-CoV-2 variants
Pengcheng Han, Chao Su, Yanfang Zhang, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 156
The Mechanism and Consequences of SARS-CoV-2 Spike-Mediated Fusion and Syncytia Formation
Maaran Michael Rajah, Annie Bernier, Julian Buchrieser, et al.
Journal of Molecular Biology (2021) Vol. 434, Iss. 6, pp. 167280-167280
Open Access | Times Cited: 154
Defining the risk of SARS-CoV-2 variants on immune protection
Marciela M. DeGrace, Elodie Ghedin, Matthew B. Frieman, et al.
Nature (2022) Vol. 605, Iss. 7911, pp. 640-652
Open Access | Times Cited: 152
Virological characteristics of the SARS-CoV-2 Omicron BA.2.75 variant
Akatsuki Saito, Tomokazu Tamura, Jiří Zahradník, et al.
Cell Host & Microbe (2022) Vol. 30, Iss. 11, pp. 1540-1555.e15
Open Access | Times Cited: 148
SARS-CoV-2 replication in airway epithelia requires motile cilia and microvillar reprogramming
Chien-Ting Wu, Peter V. Lidsky, Yinghong Xiao, et al.
Cell (2022) Vol. 186, Iss. 1, pp. 112-130.e20
Open Access | Times Cited: 138
The origins and molecular evolution of SARS-CoV-2 lineage B.1.1.7 in the UK
Verity Hill, Louis du Plessis, Thomas P. Peacock, et al.
Virus Evolution (2022) Vol. 8, Iss. 2
Open Access | Times Cited: 128
A Detailed Overview of Immune Escape, Antibody Escape, Partial Vaccine Escape of SARS-CoV-2 and Their Emerging Variants With Escape Mutations
Chiranjib Chakraborty, Ashish Ranjan Sharma, Manojit Bhattacharya, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 120
Page 1 - Next Page

Scroll to top